Skip to main content
Agricultural Biotech
What is it?
Priorities
Publications
Videos
Projects
FAQ categories
Latest newsletters
Blog
Healthcare Biotech
What is it?
Priorities
Publications
Videos
Projects
FAQ on genome editing
Industrial Biotech
What is it?
Priorities
Publications
Videos
Projects
FAQ
Cross-sector
Priorities
Publications
Videos
FAQ on Genome Editing
Search
Home
Biotechnology Industry Manifesto 2019
Biotech benefits
What is it?
Benefits
Facts & figures
Priorities
A - Z
By sector
Events
Events in Europe
Events outside Europe
About us
Who we are
Who We Are
Board & Councils
Vision, Mission & Values
Annual Reports
Members
Members
Joining EuropaBio
Staff
Newsletter
Vacancies
Contact
Social links
Tw
Li
Fb
EuropaBio
We promote an innovative and dynamic environment for the biotech industry in Europe
Menu
Close
Search
Agricultural Biotech
What is it?
Priorities
Publications
Videos
FAQ categories
Latest newsletters
Blog
Healthcare Biotech
What is it?
Priorities
Publications
Videos
Projects
FAQ on genome editing
Industrial Biotech
What is it?
Priorities
Publications
Videos
Projects
Cross-sector
Priorities
Publications
Videos
FAQ on Genome Editing
Report
Innovation & Intellectual property
Who benefits from IP rights for agricultural innovation? Full report
Ogura case study in France
who benefits-ogura_report_-_final_report_update_8oct2015
November 2014
pdf
814 kB
Report
Related contacts
Violeta
Georgieva
v.georgieva@europabio.org
+32 2 739 11 72
@VioletaGeor
Biography
